CPAC trades 7.7% below Wall Street's consensus target of $12.80.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CPAC achieves its forward estimates and maintains a stable P/E multiple of 8.2x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Cementos Pacasmayo S.A.A. (CPAC) has a Wall Street consensus price target of $12.80, based on estimates from 8 covering analysts. With the stock currently trading at $11.89, this represents a potential upside of +7.7%. The company has a market capitalization of $1.02B.
Analyst price targets range from a low of $12.80 to a high of $12.80, representing a 0% spread in expectations. The median target of $12.80 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CPAC trades at a trailing P/E of 23.8x and forward P/E of 8.2x. The forward PEG ratio of 0.42 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -31.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $38.10, with bear and bull scenarios of $24.01 and $50.21 respectively. Model confidence stands at 39/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CXCEMEX, S.A.B. de C.V. | $1.8B | $12.11 | $13.73 | +13.4% | Buy | 15.1x | 23 |
USLMUnited States Lime & Minerals, Inc. | $2.9B | $99.86 | $138.00 | +38.2% | Buy | 19.4x | 1 |
EXPEagle Materials Inc. | $6.6B | $213.02 | $220.00 | +3.3% | Buy | 16.5x | 25 |
MLMMartin Marietta Materials, Inc. | $35.8B | $594.17 | $684.55 | +15.2% | Buy | 31.1x | 40 |
VMCVulcan Materials Company | $38.9B | $299.90 | $322.10 | +7.4% | Buy | 32.5x | 36 |
CRHCRH plc | $71.0B | $106.21 | $140.92 | +32.7% | Buy | 17.9x | 20 |
BCPCBalchem Corporation | $5.4B | $168.11 | $175.50 | +4.4% | Buy | 32.1x | 10 |
CATCaterpillar Inc. | $437.4B | $940.12 | $906.87 | -3.5% | Buy | 38.1x | 56 |
DEDeere & Company | $162.9B | $603.61 | $691.58 | +14.6% | Hold | 33.4x | 46 |
DOVDover Corporation | $28.9B | $214.05 | $242.73 | +13.4% | Buy | 20.1x | 28 |
Quick answers to the most common questions about buying CPAC stock.
The consensus price target for CPAC is $12.8, close to the current price of $11.89 (7.7% implied move). Based on 8 analyst estimates, the stock appears fairly valued near current levels.
CPAC has a consensus rating of "Hold" based on 8 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $12.8 implies 7.7% upside from current levels.
With a forward P/E of 8.1955x, CPAC trades at a relatively low valuation. The consensus target of $12.8 implies 7.7% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $12.8 for CPAC, while the most conservative target is $12.8. The consensus of $12.8 represents the median expectation. Our quantitative valuation model projects a bull case target of $50 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CPAC is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CPAC stock forecast based on 8 Wall Street analysts shows a consensus price target of $12.8, with estimates ranging from $12.8 (bear case) to $12.8 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $38, with bear/bull scenarios of $24/$50.
Our quantitative valuation model calculates CPAC's fair value at $38 (base case), with a bear case of $24 and bull case of $50. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 39/100.
CPAC trades at a forward P/E ratio of 8.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
CPAC appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $12.8 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CPAC analyst price targets range from $12.8 to $12.8, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12.8 consensus represents the middle ground. Our model's $24-$50 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.